Leftagraph

Every financial statement,
one clean chart.

Search any US-listed company. Data straight from SEC filings.

PROBuild your own list with the screener

Tango Therapeutics, Inc. (TNGX) financial statements

Number look wrong? Tell us

Data table
PROBuild your own list with the screener

Tango Therapeutics, Inc. (TNGX), most recent 12 months reported: revenue $53.81M, net loss $123.72M, free cash flow -$144.25M. Latest balance sheet on file: liquid cash $1.01B. From SEC filings. Others in Pharmaceutical Preparations: AYTU BIOPHARMA, INC. · Nektar Therapeutics · PROTHENA CORPORATION PUBLIC LIMITED COMPANY · Aquestive Therapeutics, Inc. · Q32 Bio Inc. · Siga Technologies INC · GOSSAMER BIO, INC. · OCULAR THERAPEUTIX, INC

Stock screener

Watchlist